Spots Global Cancer Trial Database for newly diagnosed carcinoma of unknown primary
Every month we try and update this database with for newly diagnosed carcinoma of unknown primary cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary | NCT00357630 | Carcinoma of Un... Pain | gemcitabine hyd... quality-of-life... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin | NCT00003558 | Carcinoma of Un... | carboplatin etoposide fluorouracil leucovorin calc... paclitaxel | 18 Years - | National Cancer Institute (NCI) | |
| Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary | NCT00936702 | Carcinoma of Un... | carboplatin everolimus paclitaxel | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer. | NCT00003943 | Carcinoma of Un... Lung Cancer | filgrastim carboplatin cyclophosphamid... paclitaxel topotecan hydro... peripheral bloo... | 18 Years - | Fox Chase Cancer Center | |
| Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum | NCT00005860 | Cancer | floxuridine leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors | NCT00004922 | Carcinoma of Un... Neuroendocrine ... Neuroendocrine ... | irinotecan hydr... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies | NCT01643499 | Acinar Cell Ade... Adenocarcinoma ... Adenocarcinoma ... Adult Primary C... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Diffuse Adenoca... Duct Cell Adeno... Intestinal Aden... Localized Unres... Metastatic Carc... Metastatic Extr... Mixed Adenocarc... Mucinous Adenoc... Mucinous Adenoc... Newly Diagnosed... Signet Ring Ade... Signet Ring Ade... Stage III Pancr... Stage IIIA Colo... Stage IIIA Gall... Stage IIIA Gast... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Gall... Stage IIIB Gast... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Rect... Stage IV Gastri... Stage IV Pancre... Stage IVA Colon... Stage IVA Gallb... Stage IVA Recta... Stage IVB Colon... Stage IVB Gallb... Stage IVB Recta... Unresectable Ex... | oxaliplatin irinotecan hydr... leucovorin calc... fluorouracil laboratory biom... | 18 Years - | University of Chicago | |
| Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary | NCT00357630 | Carcinoma of Un... Pain | gemcitabine hyd... quality-of-life... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Irinotecan and Capecitabine in Treating Patients With Solid Tumors | NCT00003867 | Cancer | capecitabine irinotecan hydr... | 18 Years - 120 Years | Montefiore Medical Center | |
| Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors | NCT00004922 | Carcinoma of Un... Neuroendocrine ... Neuroendocrine ... | irinotecan hydr... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| Irinotecan and Capecitabine in Treating Patients With Solid Tumors | NCT00003867 | Cancer | capecitabine irinotecan hydr... | 18 Years - 120 Years | Montefiore Medical Center | |
| Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin | NCT00004005 | Carcinoma of Un... Colorectal Canc... Unspecified Adu... Unspecified Chi... | fluorouracil irinotecan hydr... leucovorin calc... conventional su... radiation thera... | - 24 Years | St. Jude Children's Research Hospital | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer. | NCT00003943 | Carcinoma of Un... Lung Cancer | filgrastim carboplatin cyclophosphamid... paclitaxel topotecan hydro... peripheral bloo... | 18 Years - | Fox Chase Cancer Center | |
| Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies | NCT01643499 | Acinar Cell Ade... Adenocarcinoma ... Adenocarcinoma ... Adult Primary C... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Diffuse Adenoca... Duct Cell Adeno... Intestinal Aden... Localized Unres... Metastatic Carc... Metastatic Extr... Mixed Adenocarc... Mucinous Adenoc... Mucinous Adenoc... Newly Diagnosed... Signet Ring Ade... Signet Ring Ade... Stage III Pancr... Stage IIIA Colo... Stage IIIA Gall... Stage IIIA Gast... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Gall... Stage IIIB Gast... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Rect... Stage IV Gastri... Stage IV Pancre... Stage IVA Colon... Stage IVA Gallb... Stage IVA Recta... Stage IVB Colon... Stage IVB Gallb... Stage IVB Recta... Unresectable Ex... | oxaliplatin irinotecan hydr... leucovorin calc... fluorouracil laboratory biom... | 18 Years - | University of Chicago | |
| Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin | NCT00022178 | Carcinoma of Un... | cisplatin cyclophosphamid... doxorubicin hyd... epirubicin hydr... fluorouracil vincristine sul... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer | NCT00002507 | Carcinoma of Un... Head and Neck C... | mitomycin C porfiromycin brachytherapy radiation thera... | 20 Years - 80 Years | Yale University | |
| Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary | NCT00357630 | Carcinoma of Un... Pain | gemcitabine hyd... quality-of-life... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors | NCT00004922 | Carcinoma of Un... Neuroendocrine ... Neuroendocrine ... | irinotecan hydr... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin | NCT00004005 | Carcinoma of Un... Colorectal Canc... Unspecified Adu... Unspecified Chi... | fluorouracil irinotecan hydr... leucovorin calc... conventional su... radiation thera... | - 24 Years | St. Jude Children's Research Hospital | |
| Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor | NCT00047125 | Carcinoma of Un... | radiation thera... | 18 Years - 120 Years | European Organisation for Research and Treatment of Cancer - EORTC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
